Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease
Open Access
- 1 August 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Lipid Research
- Vol. 44 (8) , 1481-1488
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Oxysterols in human circulation: which role do they have?Current Opinion in Lipidology, 2002
- Tocopherols are metabolized in HepG2 cells by side chain ω-oxidation and consecutive β-oxidationFree Radical Biology and Medicine, 2001
- Identification of genetic heterogeneity in Refsum's diseaseEuropean Journal of Human Genetics, 2000
- Lipapheresis: an immunoglobulin-sparing treatment for Refsum's diseaseActa Neurologica Scandinavica, 1996
- Cytochrome P450-Dependent Oxidation of Fatty AcidsDrug Metabolism and Drug Interactions, 1995
- Convenient highly stereoselective syntheses of (3R,7R,11R)- and (3S,7R,11R)-3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) and the corresponding 3,7,11,15-tetramethylhexadecan-1-olsThe Journal of Organic Chemistry, 1993
- Diet and Refsum's disease. The determination of phytanic acid and phytol in certain foods and the application of this knowledge to the choice of suitable convenience foods for patients with Refsum's diseaseJournal of Human Nutrition and Dietetics, 1993
- 3-METHYLADIPATE EXCRETION IN REFSUM'S DISEASEThe Lancet, 1982
- The in vitro ω-Oxidation of Phytanic Acid and Other Branched Chain Fatty Acids by Mammalian LiverScandinavian Journal of Clinical and Laboratory Investigation, 1968
- Refsum's Disease: Nature of the Enzyme DefectScience, 1967